Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03970005 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of Step-Based Care for Individuals at Clinical High Risk for Psychosis

StatusEnrolling by Invitation
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 3 years 11 months later Sep 2026 → Sep 2030
See other at-risk trials from Ohio State University

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Sep 2026 to Sep 2030
    • Secondary endpoints: details revised at 11 of 13 entries
    • Publications: details revised at 1 of 1 entry
    • Eligibility criteria expanded, about 4 words
  2. 2 versions Re-verified since Oct 28, 2024, no change to tracked fieldsv6-v7
  3. Primary and study completion dates: Apr 2024 to Sep 2026v5
  4. 2 versions Re-verified since Feb 15, 2021, no change to tracked fieldsv3-v4
  5. Secondary endpoints: 6 to 13v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The Ohio State University Early Psychosis Intervention Center is implementing a specialized clinical program to serve individuals who meet clinical high risk criteria for a psychosis. The purpose of this study is to evaluate the long-term outcomes among individuals participating in this clinical service.
Trial Details
NCT Number NCT03970005
Lead Sponsor Ohio State University
Collaborators: Substance Abuse and Mental Health Services Administration (SAMHSA)
Conditions
(from sponsor)		 Prodromal Schizophrenia
Related terms Psychotic Disorders, Schizotypal Personality Disorder
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov